Wednesday, July 8, 2026

pharma · Epilepsy · Allergic Reaction · AQST

Aquestive Therapeutics

Aquestive Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
Status
Public
HQ
Vancouver, CA
Founded
2009
Employees
75
Programs
9
Drugs
9
Patents
17
Intelligence · Clinical Programs

Aquestive Therapeutics projects

2 ClinicalTrials.gov programs sponsored by Aquestive Therapeutics.

Aquestive Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Ondansetron (ODFS)

    Aquestive Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  2. Ondansetron 8 mg ODFS without water

    Aquestive Therapeutics

    Healthy Participants

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Aquestive Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.